This has also been observed in preclinical Huntington’s Disease mouse models, indicating that mGlu5 contributes to neurodegeneration via conserved mechanisms (Abd-Elrahman et al., 2017), and suggests that antagonism of mGlu5 represents an effective approach to reverse progression of neurodegeneration by activating autophagy. Here, GRM5 is linked to juvenile Huntington disease.